![Shankar Musunuri](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shankar Musunuri
Vorstandsvorsitzender bei
OCUGEN, INC.
Vermögen: 5 Mio $ am 30.09.2026
Profil
Dr. Shankar Musunuri is an Executive Chairman & Chief Executive Officer at Ocugen OpCo, Inc., a Chairman & Chief Executive Officer at Ocugen, Inc. and a President & Secretary at OrthoCellix, Inc. Dr. Musunuri was previously employed as a Chairman & Chief Executive Officer by Ocugen, Inc. /Old/, a Founder by Nuron Biotech, Inc., a Senior Director-Global Technology Transfer by Pfizer Inc., a Principal by Amylin Pharmaceuticals, Inc., and a Principal by Wyeth LLC.
He received his MBA from The Fuqua School of Business and a doctorate degree from the University of Connecticut.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
OCUGEN INC 1,49 % | 09.10.2026 | 5 049 241 ( 1,49 % ) | 5 Mio $ | 30.09.2026 |
Aktive Positionen von Shankar Musunuri
| Unternehmen | Position | Beginn |
|---|---|---|
| OCUGEN, INC. | Vorstandsvorsitzender | 27.09.2019 |
Ocugen OpCo, Inc. | Vorstandsvorsitzender | 01.05.2015 |
Ehemalige bekannte Positionen von Shankar Musunuri
| Unternehmen | Position | Ende |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 01.01.2010 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Corporate Officer/Principal | 01.01.1996 |
Ocugen, Inc. /Old/
 Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical which develops drugs | Vorstandsvorsitzender | - |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Corporate Officer/Principal | - |
Nuron Biotech, Inc.
 Nuron Biotech, Inc. BiotechnologyHealth Technology Develops vaccines for the prevention and treatment of infectious diseases | Gründer | - |
Ausbildung von Shankar Musunuri
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
99
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Health Technology |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
University of Connecticut
 University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuron Biotech, Inc.
Nuron Biotech, Inc. BiotechnologyHealth Technology Develops vaccines for the prevention and treatment of infectious diseases | Health Technology |
The Fuqua School of Business
 The Fuqua School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ocugen, Inc. /Old/
Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical which develops drugs | Health Technology |
Ocugen, Inc.
 Ocugen, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapy products | Health Technology |
Ocugen OpCo, Inc. |
